Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInvestment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Burning Rock Biotech (BNR) EBT: 2020-2024

Historic EBT for Burning Rock Biotech (BNR) over the last 5 years, with Dec 2024 value amounting to -$46.7 million.

  • Burning Rock Biotech's EBT rose 62.11% to -$2.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$14.5 million, marking a year-over-year increase of 76.76%. This contributed to the annual value of -$46.7 million for FY2024, which is 49.11% up from last year.
  • As of FY2024, Burning Rock Biotech's EBT stood at -$46.7 million, which was up 49.11% from -$91.7 million recorded in FY2023.
  • Burning Rock Biotech's EBT's 5-year high stood at -$46.7 million during FY2024, with a 5-year trough of -$140.5 million in FY2022.
  • In the last 3 years, Burning Rock Biotech's EBT had a median value of -$91.7 million in 2023 and averaged -$93.0 million.
  • Per our database at Business Quant, Burning Rock Biotech's EBT plummeted by 100.09% in 2021 and then skyrocketed by 49.11% in 2024.
  • Burning Rock Biotech's EBT (MRY) stood at -$62.4 million in 2020, then crashed by 100.09% to -$124.9 million in 2021, then decreased by 12.53% to -$140.5 million in 2022, then soared by 34.72% to -$91.7 million in 2023, then surged by 49.11% to -$46.7 million in 2024.
  • Its last three reported values are -$46.7 million in FY2024, -$91.7 million for FY2023, and -$140.5 million during FY2022.